NCT07573995

Brief Summary

This randomized controlled trial study aims to evaluate the feasibility and preliminary efficacy of a combined inspiratory muscle training (IMT) and blood flow restriction (BFR) intervention in frail older adults. Outcomes of interest include feasibility, physical function, respiratory muscle strength, handgrip strength, five-times sit-to-stand performance, body composition, frailty level, fall efficacy, blood pressure, and adverse events.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
May 2026Oct 2026

First Submitted

Initial submission to the registry

April 23, 2026

Completed
8 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 7, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

5 months

First QC Date

April 23, 2026

Last Update Submit

May 1, 2026

Conditions

Keywords

frailtyolder adultsblood flow restrictioninspiratory muscle training

Outcome Measures

Primary Outcomes (6)

  • Recruitment rate

    The recruitment rate will be calculated by dividing the number of recruited participants by the number of eligible participants

    T0 = baseline; T1 = immediately after intervention

  • Attrition rate

    Attrition rate is the proportion of randomized participants who withdraw from the study or are lost to follow-up before completing the final assessment.

    T0 = baseline; T1 = immediately after intervention

  • Exercise Enjoyment

    Enjoyment will be assessed using a single-item Exercise Enjoyment Scale, which asks participants, "How much did you enjoy the exercise session?). Responses are rated on a 7 Likert scale ranging from 1 (not at all) to 7 (extremely)

    T0 = baseline; T1 = immediately after intervention

  • Short Physical Performance Battery (SPPB)

    The SPPB consists of three components-standing balance, gait speed, and repeated chair stands-each scored from 0 to 4 and summed to a total score ranging from 0 (worst performance) to 12 (best performance). Lower SPPB scores indicate poorer physical function and a higher risk of adverse outcomes, with scores below 10 predictive of all-cause mortality in older adults.

    T0 = baseline; T1 = immediately after intervention

  • 6-Minute Walk Test (6MWT)

    The 6MWT will be used to assess functional exercise capacity. Participants will be instructed to walk as far as possible along a flat, straight course for 6 minutes, and the total distance is recorded.

    T0 = baseline; T1 = immediately after intervention

  • Time Up to Go (TUG)

    The TUG test is used to assess functional mobility, balance, and fall risk in older adults, incorporating a series of dynamic activities. Participants will be instructed to rise from a chair, walk three meters at a comfortable pace, turn around, walk back to the chair, and sit down. The total time taken to complete the task is recorded, with longer times indicating poorer functional mobility and higher fall risk

    T0 = baseline; T1 = immediately after intervention

Secondary Outcomes (8)

  • Respiratory Muscle Strength

    T0 = baseline; T1 = immediately after intervention

  • Handgrip Strength

    T0 = baseline; T1 = immediately after intervention

  • Five-times sit-to-stand

    T0 = baseline; T1 = immediately after intervention

  • Frailty level

    T0 = baseline; T1 = immediately after intervention

  • Fall Efficacy

    T0 = baseline; T1 = immediately after intervention

  • +3 more secondary outcomes

Other Outcomes (2)

  • The Borg Rating of Perceived Exertion (RPE) Scale

    T0 = baseline; T1 = immediately after intervention

  • Automated Office Blood Pressure

    T0 = baseline; T1 = immediately after intervention

Study Arms (2)

Intervention group

EXPERIMENTAL

Participants in the experimental group will receive a 6 week combined BFR and IMT intervention

Behavioral: Exercise

Control group

SHAM COMPARATOR

Participants in the control group will receive a 6-week combined combined BFR and sham IMT intervention.

Behavioral: Sham Control

Interventions

ExerciseBEHAVIORAL

Each session will last approximately 60 minutes and will include three components: (1) an initial 3-minute IMT exercise performed at an intensity corresponding to rating of perceived exertion (RPE) 11-13 on the Borg 6-20 scale, (2) a 50-minute low-intensity exercise program combined with BFR, and (3) a second 3-minute IMT session at the same target intensity. For the IMT, the protocol follows a progressive intensity model, starting with 30% of the maximum inspiratory pressure (MIP) in Week 1 to allow participants to become familiar with the technique. The intensity will gradually increase to a target of 60% MIP by Week 6, based on the participants' tolerance. For the BFR, during weeks 1-2, participants will train at constant loads. From weeks 2-6, training loads will be increased. Cuff pressure will be prescribed relative to the calculated arterial occlusion pressure (AOP): 50% in weeks 1-2, 60% in weeks 3-4, and 70% in weeks 5-6 for both lower- and upper-body exercises.

Intervention group
Sham ControlBEHAVIORAL

Participants in the control group will perform the identical BFR exercise protocol as the intervention group. However, IMT will be delivered at 2% of MIP, which is considered a sham condition and has not been shown to improve respiratory muscle function

Control group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Community-dwelling adults aged 65 years and older who are classified as at least "vulnerable" using the Clinical Frailty Scale (score ≥4).
  • Participants must have no cognitive impairment and be able to follow commands, as assessed by the Mini-Mental State Examination (MMSE).

You may not qualify if:

  • (1) are unable to participate in exercise (e.g., due to severe musculoskeletal disorders)
  • (2) have high-risk factors for exercise, such as uncontrolled hypertension (\>150 mmHg systolic blood pressure (SBP) / \>90 mmHg diastolic blood pressure (DBP), coagulation disorders, and deep venous thrombosis
  • (3) have hematological disorders or are using hematology related-medications
  • (4) have significant comorbidities, including a history of stroke, diabetes with severe complications, or cardiovascular diseases
  • (5) chronic lung conditions (e.g., obstructive pulmonary disease, asthma), and
  • (6) have participated in a structured exercise training program within the past 3 months at a frequency exceeding three sessions per week.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical University

Taipei, 11031, Taiwan

Location

MeSH Terms

Conditions

Frailty

Interventions

Exercise

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Pei-Shan Tsai Professor, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
We will implement a double-masking protocol, ensuring that participants and outcome assessors are all blinded to group assignments. Additionally, group assignments will also be masked from the data analyzer to minimize potential bias.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 23, 2026

First Posted

May 7, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

May 7, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations